Test Research, Inc. Stocks

NT$ 313Last Updated 27.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

NT$ 2.35B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 313
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Test Research, Inc. designs, assembles, manufactures, maintains, repairs, and sells automated inspection and testing equipment in Asia, America, Europe, and internationally. The company offers optical inspection solutions, including 3D solder paste inspection, pre-reflow and post- reflow automated optical inspection, and automated X-ray inspection systems; and manufacturing defects analyzers and in-circuit testers. It also provides smart factory and AI-power solutions, as well as yield management system. In addition, the company offers test and inspection solutions for automotive, semiconductor, and telecommunication industries. Further, it provides after sales services, including trouble shooting, failure analysis, periodic calibration, system maintenance, and parts and accessories warranty. Test Research, Inc. was incorporated in 1989 and is headquartered in Taipei City, Taiwan.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, overpric

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks